Previous close | 9.43 |
Open | 9.73 |
Bid | 10.03 x 200 |
Ask | 10.13 x 100 |
Day's range | 9.72 - 10.19 |
52-week range | 3.81 - 17.70 |
Volume | |
Avg. volume | 292,537 |
Market cap | 594.8M |
Beta (5Y monthly) | 0.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IGM Biosciences (IGMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Over the last year, a good number of insiders have significantly increased their holdings in IGM Biosciences, Inc...